| __timestamp | Telix Pharmaceuticals Limited | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22622695 | 54823000000 |
| Thursday, January 1, 2015 | 24863028 | 76691000000 |
| Friday, January 1, 2016 | 21351001 | 87477000000 |
| Sunday, January 1, 2017 | 53837297 | 89052000000 |
| Monday, January 1, 2018 | 16080096 | 100745000000 |
| Tuesday, January 1, 2019 | 18525736 | 91915000000 |
| Wednesday, January 1, 2020 | 2024000 | 95905000000 |
| Friday, January 1, 2021 | 2548000 | 104442000000 |
| Saturday, January 1, 2022 | 61556000 | 104437000000 |
| Sunday, January 1, 2023 | 188157000 | 112009000000 |
| Monday, January 1, 2024 | 121134000000 |
Unlocking the unknown
In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding cost dynamics is crucial. Walgreens Boots Alliance, Inc., a retail giant, and Telix Pharmaceuticals Limited, a biotech innovator, present a fascinating study in contrasts. From 2014 to 2023, Walgreens consistently reported a cost of revenue exceeding $50 billion annually, peaking at $112 billion in 2023. This reflects its expansive retail operations and global reach. In contrast, Telix, a smaller player, saw its cost of revenue grow from $2 million in 2020 to $188 million in 2023, marking a staggering 9,300% increase. This surge underscores Telix's rapid expansion and investment in innovative therapies. Notably, data for 2024 is missing for Telix, hinting at potential reporting delays or strategic shifts. This comparison highlights the diverse financial strategies within the industry, offering insights into operational scale and growth trajectories.
Cost of Revenue Trends: Johnson & Johnson vs Walgreens Boots Alliance, Inc.
Cost of Revenue Comparison: Amgen Inc. vs Walgreens Boots Alliance, Inc.
Cost Insights: Breaking Down Sanofi and Telix Pharmaceuticals Limited's Expenses
Comparing Cost of Revenue Efficiency: Bristol-Myers Squibb Company vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Zoetis Inc. vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Bio-Techne Corporation vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Amneal Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Walgreens Boots Alliance, Inc. vs ADMA Biologics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Walgreens Boots Alliance, Inc. and Travere Therapeutics, Inc.
Cost of Revenue: Key Insights for Exelixis, Inc. and Telix Pharmaceuticals Limited
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Telix Pharmaceuticals Limited